Geospatial analysis of the influence of family doctor on colorectal cancer screening adherence
Authors:
Fabrizio Stracci aff001; Alessio Gili aff002; Giulia Naldini aff003; Vincenza Gianfredi aff003; Morena Malaspina aff004; Basilio Passamonti aff004; Fortunato Bianconi aff002
Authors place of work:
Department of Experimental Medicine, Public Health Section, University of Perugia, Perugia, Italy
aff001; Umbria Cancer Registry, Perugia, Italy
aff002; School of Specialization in Hygiene and Preventive Medicine, University of Perugia, Perugia, Italy
aff003; Azienda USL Umbria 1,Laboratorio Unico di Screening, Perugia, Italy
aff004
Published in the journal:
PLoS ONE 14(10)
Category:
Research Article
doi:
https://doi.org/10.1371/journal.pone.0222396
Summary
Background
Despite the well-recognised relevance of screening in colorectal cancer (CRC) control, adherence to screening is often suboptimal. Improving adherence represents an important public health strategy. We investigated the influence of family doctors (FDs) as determinant of CRC screening adherence by comparing each FDs practice participation probability to that of the residents in the same geographic areas using the whole population geocoded.
Methods
We used multilevel logistic regression model to investigate factors associated with CRC screening adherence, among 333,843 people at their first screening invitation. Standardized Adherence Rates (SAR) by age, gender, and socioeconomic status were calculated comparing FDs practices to the residents in the same geographic areas using geocoded target population.
Results
Screening adherence increased from 41.0% (95% CI, 40.8–41.2) in 2006–2008 to 44.7% (95% CI, 44.5–44.9) in 2011–2012. Males, the most deprived and foreign-born people showed low adherence. FD practices and the percentage of foreign-born people in a practice were significant clustering factors. SAR for 145 (21.4%) FDs practices differed significantly from people living in the same areas. Predicted probabilities of adherence were 31.7% and 49.0% for FDs with low and high adherence, respectively.
Discussion
FDs showed a direct and independent effect to the CRC screening adherence of the people living in their practice. FDs with significantly high adherence level could be the key to adherence improvement.
Impact
Most deprived individuals and foreigners represent relevant targets for interventions in public health aimed to improve CRC screening adherence.
Keywords:
Public and occupational health – Socioeconomic aspects of health – Age groups – Cancer screening – Census – Italian people – Geographic areas – colorectal cancer
Introduction
Colorectal cancer (CRC) is the third most frequent cancer in men and the second in women worldwide [1] and represents the fourth cancer cause of death globally [2]. Incidence is higher in more developed countries (ASR world: 36.3 among males and 23.6 among females) than in less developed regions (ASR world: 13.7 among males and 9.8 among females) [1]. Although many modifiable risk factors for colorectal cancer are well-established (e.g., high consumption of red and processed meat, obesity, smoking, etc.), primary prevention requires considerable efforts [2,3]. Indeed, the adoption of westernised diet and habits has been associated with increasing colorectal cancer incidence and mortality in Eastern Europe and in other medium to high health development index (HDI) countries [4,5]. Thus, screening assumes great relevance in colorectal cancer control, particularly where primary prevention efforts are lacking [6,7]. Italy, together with other high HDI countries, shows high incidence rates of large bowel cancer [4]. Many Italian regions started screening programs based on the fecal immunochemical test (FIT) in the middle 2000s [8]. Eligible individuals are actively invited to CRC screening; participation in the program is free of charge. Despite suboptimal CRC screening adherence (Italian average 47% in 2010–2011) [9–11], CRC FIT-based screening has already determined a significant reduction in disease specific incidence and mortality in Italy [12,13].
In Umbria, a central Italian region, organized CRC FIT-based screening started in 2006. The regional program has some specificities in the Italian CRC screening landscape. While in the other Italian regions the age span for CRC screening is 50–69 years, in Umbria the target age group includes individuals aged 50–74 years, according to international guidelines [14,15]. The Umbrian population is among the oldest in the world with a long life expectancy (e.g., life expectancy at the age of 65 in 2016 both sexes, 21.2 years, source ISTAT [16]). An outreach approach was adopted. Measures to reduce barriers and to ensure high levels of adherence have been embedded in the screening program since its introduction (e.g., mailed kit, kit returned directly by priority mail, involvement of FDs) but the corrected participation reached only 45% at the first (prevalence) time and 49% at the last study round [11]. Since adherence to CRC screening is generally low, improving participation represents an important public health strategy to fully exploit the benefits of an organized screening program [8,17,18].
We investigated the determinants of screening adherence in the regional population introducing a new geographical analysis of the geocoded population. In particular, we focused on the influence of individual factors and clustering factors corresponding to health service components (i.e., FDs, health district).
Methods
Study population
Data on the uptake of CRC screening were obtained from the Regional screening services. Regional prevention program was approved by Regional Government of Umbria, Management of Health and Welfare. Contact for the screening program is Dr. Basilio Passamonti, also one of the authors of this paper. Data were managed according to ISO 27001, EU General Data Protection Regulation and informed consent was obtained from all subjects included in the study. During the study period 2006–2012, overall 333,843 people aged 50–74 years were invited over three screening rounds, generating 726,742 screening invitations. Inclusion criteria were: residency in Umbria, no colonoscopy or colectomy in the preceding 5 years, no CRC screening test in the last 2 years and no personal history of CRC. In the present analyses, we considered adherence to the first screening invitation for 320,534 people (153,365 males, 47.8%). We performed further analyses on the adherence to any of the three study rounds (Fig 1).
Study variables
We considered residence, socioeconomic status (SES), birth nationality, gender and age group as individual level determinants of CRC screening adherence. FD and health district (HD) were explored as clustering variables. Features of study clusters, such as the percentage of immigrants in a FDs practice, were also included in the models as cluster-level factors. Municipalities having less than 300 ab. over km2 were coded as rural. Overall, there were 15,164 (4.7%) people born abroad among the invited. The 3,909 (1.2%) people born in Western Europe were included in the Italian population, as their adherence rates were comparable to the Italian one. We considered nationality of birth as a proxy for ethnic and cultural minorities. The percentage of foreigners by cluster was also included in the analyses. SES was measured at the census tract level (micro-ecologic) using the national deprivation index (NDI). NDI is based on 5 variables (low level of education, unemployment, lack of home ownership, one parent family and overcrowding) obtained from the Italian population census (census 2001) [19] to include in a single indicator the multiple aspects of deprivation [20]. Due to incomplete information, NDI was missing for 7,166 (2.2%) invited individuals. The average number of inhabitants per census tract was 121 (min 0, max 1,475). The number of FDs was 867. FD was missing for 8,757 patients (2.6%), mainly because of recent change of residence, and was associated with a very low crude participation (11.8%). Missing FD was more prevalent among foreign-born individuals (4,483, 22.0%) than among Italians (4,274, 1.4%), reflecting the higher mobility of this population. FDs with few invited patients (i.e., < 100) were excluded from the analyses (n. 191); overall, these FDs had 4,552 (1.4%) invited patients only (Fig 1).
The areas covered by Italian local health units divide into HDs. HDs provide specialist out-patient care and other services, promote preventive activities and coordinate the FDSs activities. In Umbria, the Regional health service consists of two local health units, each including 6 HDs. The average number of invited population per district was 27,526 with a mean of 43 FDs per district (range 10–103).
Geocoding
An extension of the Information Systems presented in [21] called GeCO-sys and based on Google Maps Geocoding API was used for geocoding and 98.7% of invited individuals were successfully geocoded. Population geocoding results were compared to age group population data from the National Institute of Statistics (ISTAT) at census level (2011). FDs were mapped using the centroid/baricentre of their patients’ addresses.
Statistical analysis
The chi-square test assessed the impact of study variables on CRC screening participation. Results were deemed significant at the usual alpha level (0.05).
We calculated simple standardized adherence rates (SARs) by gender, age and SES. SARs over a selected area (S), i.e., triangular or hexagonal area, census section, or municipal level, were obtained using the following formula: where aSi was the number of adherence events in the i-th stratum of the study population (e.g. sex, age classes are the variables to stratify the population), RSi was the adherence event rate in the i-th stratum of the regional standard invited population and ISi was the size of the i-th stratum of the invited population. The smallest partition considered was the triangular area (0.68 km2, on average 111 invited residents, 48% males).
To investigate the role of FDs and FDs practices, we compared adherence in a FDs practice with adherence in the general population living in the same areas by local SARs. We defined the SFD area as the polygon including areas (e.g., triangular areas) containing at least one FD patient (Fig 1A). The weighted FD SAR was: where aFDi was the number of observed adherent FDs patients in the i-th stratum, wSFDi was the ratio of adherent population aSFDi over the invited population ISFDi in the area SFDi and IFDi was the invited FDs population. A 95% confidence interval was calculated for SARS and wSARSFD.
We fitted a set of multilevel logistic regression models to investigate the influence of study variables on screening adherence [22]. Invited individuals (level 1) were considered clustering by FDs practice (level 2).
First, we fitted a random intercept empty model (i.e., without fixed effects variables) to test the influence of FDs on adherence. A second logistic regression model investigated individual-level variables as independent determinants of adherence. Then, we fitted a multi-level model including significant individual variables (fixed effects) and allowed the adherence by FDs practice to vary randomly.
The final model was selected using the Bayesian information criterion (BIC)[23]. The selected model allowed the random variation of both the intercept for FDs practices and the coefficient for the percentage of foreigners in a FDs practice and it took the following form: where the vector with fixed effects (xij) was denoted by β and the vector with the random effects (zij) shared by all level-1 units i, i = 1,…,nj, belonging to the j-th level-2 unit j, i = 1,…,n, by uj. πij = E(yij|xij,zij,uj) was the conditional expectation of binary response yij.
Finally, we fitted two multilevel models for FDs practices respectively with significantly higher and lower local wSARSFD than the residents in the same areas.
The variance partition coefficient (VPC) was calculated as a measure of the variability explained by clustering variables (e.g., variance due to adherence levels by FDs practices or HD). In our two-level models with random intercept and random coefficient, VPC is the same as the intraclass correlation coefficient (ICC) due to a zero value for the slope variable, which is a measure of correlation among individuals belonging to the same cluster.
In a multilevel model, it is not possible to estimate the odds ratios for cluster-level variables and this poses some difficulties for the interpretation of the influence of such variables. To overcome this limitation, additional measures were proposed for cluster-level variables (reviewed in [24]). We also calculated the median odds ratio (MOR) to further illustrate the adherence heterogeneity between clusters [24]. MOR represents the median value of the odds ratio in the distribution of pairwise comparisons between subjects with equal values of covariates but belonging to different clusters. The MOR assumes values ≥1, with 1 indicating no variation among clusters. MOR is expressed in the odds ratio scale and can be properly compared to the fixed-effects odds ratios to quantify the cluster effect. The MOR can be interpreted as the (median) change in risk for an individual moving from a cluster at lower risk to another at higher risk [25].
Predicted adherence probabilities at average covariates values were calculated based on the two models above and, for comparison, using model 1, over the same selected FD practices.
We performed all analyses using Stata statistical software [26] and the GeoMap module of GeCOsys for geocoded data [21].
Results
Adherence to the CRC screening program, excluding spontaneous participation, increased from 41.0% (95% CI, 40.8–41.2) in 2006–2008 to 44.7% (95% CI, 44.5–44.9) in 2011–2012. Among individuals invited for the first time to CRC screening, overall adherence was 40.2% (95% CI, 40.1–40.4) (S1 Fig). The distribution of participation by study variable is shown in Table 1. Adherence to at least one invitation was 53.0% (95% CI, 52.8–53.1). Low screening adherence was observed for the foreign-born, the less deprived quintile, the youngest and oldest age groups, and males. Median adherence by FDs practice was 41% and ranged from 21% to 57% (IQR 8%).
The maps of standardized screening participation (SARS) by municipality, gender and deprivation are shown in Fig 2. Male gender and the most deprived were associated with low CRC screening adherence.
In regression modelling, after estimating random intercept of empty model (i.e., without fixed effects variables) a significant independent effect on participation was observed for FDs practice (LR test p<0.00001), disclosing that the between FDs variance is non-zero).
Then, fixed effects for gender, age, birth nationality, round and NDI were included in the multilevel model with FDs practice as a cluster level variable. Urban/rural variable was non-significant and thus was excluded from the model. The model with the lowest BIC included the percentage of foreigners in each FDs practice as random coefficient (LR test p<0.00001 vs random intercept model only) (Table 2, model 1). The odds ratios for fixed effects remained unchanged to the second decimal place after the inclusion of foreign born people as a FDs practice factor. The VPC for random effects in model 1 was 7.8%. The MOR for the FDs effect was 1.12, similar to the OR estimated for deprivation effect.
The ever-adherent model (Table 2, model 2) was similar to the first invitation adherent model. Age showed the same U shape with lower adherence observed for the youngest and oldest screening age groups but in model 2, intermediate age showed lower odds ratios.
In the empty model including the health district instead of FDs practice, clustering by health district was also significant (LR test p = 0.023). However, in the multilevel model with fixed effects, HD explained almost no variability (VPC 0.006%) and was associated with a MOR as low as 1.002 (corresponding figures for the model including FDs practices were 4.8% and 1.11).
Thus the VPCs and MORs from multilevel models point to a moderate to important influence of FDs practice and a negligible influence of district on adherence.
Locally weighted SARs comparing individuals in a FDs practice to residents in the same area are shown in Fig 3 panel A. In particular, we found that, respectively, 91 and 54 FD practices had local wSARSFDj significantly higher or lower than the population living in the same areas (Fig 3 panel B). We compared adherence levels for high, average, and low FDs practice to further clarify the influence of FDs. Locally weighted SARs ranged from 51.4% to 152.4% and crude adherence probabilities from 21.0% to 57.0%. Foreign-born individuals were 5.0% among FD practices with low adherence and only 3.1% among practices with high adherence. However, the foreign-born showed a significantly higher adherence in the FD practices with high adherence than in the ones with low adherence (35.8 vs 25.7%, chi-square test p<0.0001).
Predicted adherence probabilities obtained from multilevel models including only significant FDs practices are illustrated in Fig 3 panel B. (see S1 Table for models). FDs practices with high level of adherence showed a 49% probability of adherence at first invitation whereas the corresponding Figure for FDs with low adherence was only 32%. To rule out the possibility that different adherence levels stemmed from clustering of individuals with unfavourable distribution of fixed-effect variables, we used the model including all invited people (model 1) to predict adherence for high, average, and low FDs practices. Indeed, the average predicted probabilities of adherence for individuals belonging to different FD practices was similar.
Discussion
We found that FDs practices had a significant influence on colorectal cancer screening adherence in an organized screening setting. In terms of both explained variance and median odds ratio, the influence of FDs practice was important, after accounting for individual-level variables. In our study, clustering by FDs practice was associated with a magnitude of effect comparable to being in the most deprived group.
Population geocoding [21] allowed a new analysis comparing people in a FDs practice to people living in the same area. Three FDs groups were identified: a. n.91 (13.5%) physicians with patient participation significantly higher than people living in the same geographic area (“promoters”); b. n.54 (8%) physicians with significant low adherence (“opponents”) and c. the majority (n.531, 78.5%) of physicians, showing similar participation rates to the area population (“non-influential”). These findings provide additional evidence for the role of FDs behavior in determining CRC screening adherence. Based on models stratified by FDs group, we estimated that individuals in a promoter FDs practice had an adherence probability 17% higher than individuals in opponent FDs practices and 9% higher than the adherence probability for an invited person at average covariates values. The observed gap was not due to an imbalance in individual level covariates by FDs group (Fig 3).
Screening recommendation by FDs is a facilitator of participation [27,28]. Notably, in our study FDs were associated with different screening behaviours, even though they were involved in the organized screening program. Indeed, FDs signed the invitation letter [29], received a list of their patients non-attending screening or colonoscopy after a positive FIT result [30], and received financial incentives for high participation levels [31].
Further research will explore FDs clinical practice to identify activities and attitudes associated with successful or unsuccessful adherence rates. Diffidence toward cancer screening and/or the preference of screening modalities other than fecal testing could possibly explain the different FDs attitude [32–34].
The FDs perception of barriers to CRC screening participation results in significantly different FDs performances, as reported by Weiss et al. [35]. Barrier identification and perception may relate to active FD involvement in the screening campaign.
FDs association in mono- or multidisciplinary teams and their collaboration with health professionals (e.g., nurses) in promoting preventive interventions may have contributed to the observed variability and should be further investigated [36].
Clustering factors (e.g., selection of people with characteristic adherence rate in a practice) may also have contributed to our results. Indeed, the percentage of foreign-born patients in a FD practice was a significant clustering factor. The reduced screening participation could be due to linguistic or cultural barriers of a specific ethnic community, which could partially explain their tendency to group within the same FD practice [37]. Furthermore, a high percentage of foreign-born individuals in a FD practice could be associated with other established determinants of lower screening adherence (e.g., low educational levels, low income). Since FDs practices do have a geographic basis, the percentage of foreign-born individuals could be an indicator of neighbourhood deprivation, thereby linked to screening adherence [38]. Interestingly, the promoter FDs group had a low percentage of immigrants but with a relatively high screening adherence if compared to opponent FDs group.
The association between being born abroad and belonging to the most deprived quintile and to an opponent FD practice, resulted in a strikingly low screening participation (25.2%). Considering the low adherence to CRC screening registered in our study, foreign-born individuals represent a valid target for public intervention. Moreover, the relevance of immigrant participation will increase, as an increasing number of foreign-born people will match the age eligibility criteria for CRC screening in the near future. The percentage of invited foreigners was less than 6% in our study, but the percentage of residents born abroad in the pre-screening age (30–50 years old) was 20.8% in 2013 (data from the national institute of statistics ISTAT [39]).
With a much lower explained variance than FD practice, the local health district had almost no influence on screening adherence. This negative finding was surprising, as the HD is appointed to coordinate public health and FDs activity (particularly the team-based ones) and thus should play a relevant role in disease prevention.
Additional individual-level factors affected CRC screening participation, such as socioeconomic status, being born abroad and gender. People with a low SES level participated less in CRC screening. In our study, the decrease in participation rates started in the fourth quintile of deprivation and reached a probability as low as 39% among the most deprived. The impact of deprivation on CRC screening adherence has been described in several studies. In the UK, CRC screening uptake varied from 35% in the most deprived quintile to 61% in the least deprived quintile (overall participation 54%) [40] and Pornet et al. reported a similar gap for the most deprived [41]. In the French study, however, the least deprived participated in screening more than the intermediate socioeconomic status levels.
Being part of an ethnic minority and having a low income are significant barriers to screening participation in the majority of published studies [28].
Previous evidence showed that organized screening reduces the socioeconomic gradient in adherence to this preventive intervention, even though it does not eliminate the inequalities when compared to opportunistic screening [42]. Despite the availability of effective measures in a FDs practice which could improve screening adherence, tailored actions to reduce the impact of SES inequalities on participation should be further investigated [43]. Gupta et al. improved screening adherence through multilingual, low-literacy, educational brochures and reminder phone calls [44]. A similar intervention could be feasible and appropriate in our regional context.
In contrast with other studies [45], we found no effect of rural residence on screening participation, which is probably attributable to the minimal travel effort required by the test kit administration.
In our study, women were more likely to participate in the FIT-based CRC screening, in accordance with other studies [46] but more frequently the female gender represents a barrier to adherence [28]. The importance of participation in CRC screening among men is remarkable, since scientific evidence attributes the greatest benefit from CRC screening to males [47]. Age <65 years represented a barrier to screening participation in most studies [28]. In our study, age had a U-shaped influence on adherence. Reduced adherence in the youngest invited age group may depend either on an underestimation of CRC risk or on the perception of the screening invitation as a modern rite of passage into old age [48]. The oldest invited age group showed a reduced adherence in our study, despite the adoption of measures aimed to reduce geographical barriers and travel difficulties (e.g., mailed kit, test return by mail). No univocal result is reported in the published literature results for this age group [49,50].
Our study has limitations. Data on cluster lever covariates, which could explain variability by FDs practices, including FDs attitude about screening, were lacking. The SES indicator used in our study was available at census tract level (micro-ecologic) and not at an individual level. Moreover, the NDI index could have a reduced ability to measure socioeconomic status among immigrants [51].
Conclusions
Adherence to CRC screening was low in our study. Thus, public health measures to improve participation in the regional population would be appropriate. In addition, targeted actions should be designed to increase screening adherence among males, the foreign-born and the most deprived. We showed that FDs practice influences screening participation by comparing adherence in a FD practice to that of people living in the same geographic area. In particular, “promoter” FDs practices with high adherence rates could provide effective models to improve screening participation.
Supporting information
S1 Fig [tif]
Regional screening adherence map of SAR by municipality and gender for all cases.
S1 Table [docx]
Estimated odds ratios of adherence to CRC screening program with multilevel logistic regression models for FDs practices respectively with significantly higher (model 3) and lower (model 4) local than the residents in the same areas: Random variation of the intercept for FDs practices and the coefficient for the percentage of foreigners for adherents.
Zdroje
1. Ferlay J, Soerjomataram I, Ervik M, Dikshit R, Eser S, Mathers C, et al. GLOBOCAN 2012 v1. 0, Cancer Incidence and Mortality Worldwide: IARC CancerBase No. 11. Lyon, France: International Agency for Research on Cancer; 2013. 2015.
2. Brenner H, Kloor M, Pox CP. Colorectal cancer. Lancet (London, England). Elsevier; 2014;383: 1490–1502. doi: 10.1016/S0140-6736(13)61649-9 24225001
3. Meyskens FL, Mukhtar H, Rock CL, Cuzick J, Kensler TW, Yang CS, et al. Cancer Prevention: Obstacles, Challenges, and the Road Ahead. JNCI J Natl Cancer Inst. 2016;108. doi: 10.1093/jnci/djv309 26547931
4. Arnold M, Sierra MS, Laversanne M, Soerjomataram I, Jemal A, Bray F. Global patterns and trends in colorectal cancer incidence and mortality. Gut. 2017;66: 683–691. doi: 10.1136/gutjnl-2015-310912 26818619
5. Fidler MM, Bray F, Vaccarella S, Soerjomataram I. Assessing global transitions in human development and colorectal cancer incidence. Int J Cancer. 2017;140: 2709–2715. doi: 10.1002/ijc.30686 28281292
6. Stracci F, Zorzi M, Grazzini G. Colorectal Cancer Screening: Tests, Strategies, and Perspectives. Front Public Heal. 2014;2: 210. doi: 10.3389/fpubh.2014.00210 25386553
7. Naishadham D, Lansdorp-Vogelaar I, Siegel R, Cokkinides V, Jemal A. State Disparities in Colorectal Cancer Mortality Patterns in the United States. Cancer Epidemiol Biomarkers Prev. 2011;20: 1296–1302. doi: 10.1158/1055-9965.EPI-11-0250 21737410
8. Giorgi Rossi P, Carrozzi G, Federici A, Mancuso P, Sampaolo L, Zappa M. Invitation coverage and participation in Italian cervical, breast and colorectal cancer screening programmes. J Med Screen. SAGE PublicationsSage UK: London, England; 2018;25: 17–23. doi: 10.1177/0969141317704476 28614991
9. Senore C, Inadomi J, Segnan N, Bellisario C, Hassan C. Optimising colorectal cancer screening acceptance: a review. Gut. 2015;64: 1158–1177. doi: 10.1136/gutjnl-2014-308081 26059765
10. Swan J, Breen N, Graubard BI, McNeel TS, Blackman D, Tangka FK, et al. Data and trends in cancer screening in the United States. Cancer. 2010;116: 4872–4881. doi: 10.1002/cncr.25215 20597133
11. Lo screening colorettale | Osservatorio Nazionale Screening [Internet]. [cited 9 Jul 2018]. Available: https://www.osservatorionazionalescreening.it/content/lo-screening-colorettale
12. Zorzi M, Fedeli U, Schievano E, Bovo E, Guzzinati S, Baracco S, et al. Impact on colorectal cancer mortality of screening programmes based on the faecal immunochemical test. Gut. 2015;64: 784–790. doi: 10.1136/gutjnl-2014-307508 25179811
13. Giorgi Rossi P, Vicentini M, Sacchettini C, Di Felice E, Caroli S, Ferrari F, et al. Impact of Screening Program on Incidence of Colorectal Cancer: A Cohort Study in Italy. Am J Gastroenterol. 2015;110: 1359–1366. doi: 10.1038/ajg.2015.240 26303133
14. Bibbins-Domingo K, Grossman DC, Curry SJ, Davidson KW, Epling JW, García FAR, et al. Screening for Colorectal Cancer: US Preventive Services Task Force Recommendation Statement. JAMA. 2016;315: 2564. doi: 10.1001/jama.2016.5989 27304597
15. Halloran S, Launoy G, Zappa M, International Agency for Research on Cancer. European guidelines for quality assurance in colorectal cancer screening and diagnosis.–First Edition Faecal occult blood testing. Endoscopy. 2012;44: SE65–SE87. doi: 10.1055/s-0032-1309791
16. Indicatori demografici [Internet]. [cited 6 Aug 2018]. Available: http://dati.istat.it/Index.aspx?DataSetCode=DCIS_INDDEMOG1&Lang=it
17. Smith SG, Wardle J, Atkin W, Raine R, McGregor LM, Vart G, et al. Reducing the socioeconomic gradient in uptake of the NHS bowel cancer screening Programme using a simplified supplementary information leaflet: a cluster-randomised trial. BMC Cancer. 2017;17: 543. doi: 10.1186/s12885-017-3512-1 28806955
18. Frazier AL, Colditz GA, Fuchs CS, Kuntz KM. Cost-effectiveness of screening for colorectal cancer in the general population. JAMA. 2000;284: 1954–61. Available: http://www.ncbi.nlm.nih.gov/pubmed/11035892 doi: 10.1001/jama.284.15.1954 11035892
19. Caranci N, Biggeri A, Grisotto L, Pacelli B, Spadea T, Costa G. The Italian deprivation index at census block level: definition, description and association with general mortality. Epidemiol Prev. 2010;34: 167–176. 21224518
20. Krieger N, Williams DR, Moss NE. Measuring Social Class in US Public Health Research: Concepts, Methodologies, and Guidelines. Annu Rev Public Health. 1997;18: 341–378. doi: 10.1146/annurev.publhealth.18.1.341 9143723
21. Bianconi F, Brunori V, Valigi P, La Rosa F, Stracci F. Information technology as tools for cancer registry and regional cancer network integration. IEEE Trans Syst Man, Cybern Part ASystems Humans. 2012;42. doi: 10.1109/TSMCA.2012.2210209
22. Austin PC, Merlo J. Intermediate and advanced topics in multilevel logistic regression analysis. Stat Med. 2017;36: 3257–3277. doi: 10.1002/sim.7336 28543517
23. Neath AA, Cavanaugh JE. The Bayesian information criterion: background, derivation, and applications. Wiley Interdiscip Rev Comput Stat. Wiley-Blackwell; 2012;4: 199–203. doi: 10.1002/wics.199
24. Larsen K, Petersen JH, Budtz-Jørgensen E, Endahl L. Interpreting parameters in the logistic regression model with random effects. Biometrics. 2000;56: 909–14. Available: http://www.ncbi.nlm.nih.gov/pubmed/10985236 10985236
25. Merlo J, Chaix B, Ohlsson H, Beckman A, Johnell K, Hjerpe P, et al. A brief conceptual tutorial of multilevel analysis in social epidemiology: using measures of clustering in multilevel logistic regression to investigate contextual phenomena. J Epidemiol Community Heal. 2006;60: 290–297. doi: 10.1136/jech.2004.029454 16537344
26. Stata Statistical Software: Release 14. In: StataCorp. [Internet]. 2015 [cited 31 Aug 2017]. Available: https://www.stata.com/support/faqs/resources/citing-software-documentation-faqs/
27. Rat C, Latour C, Rousseau R, Gaultier A, Pogu C, Edwards A, et al. Interventions to increase uptake of faecal tests for colorectal cancer screening. Eur J Cancer Prev. 2017;27: 1. doi: 10.1097/CEJ.0000000000000344 28665812
28. Wools A, Dapper EA, Leeuw JRJ de. Colorectal cancer screening participation: a systematic review. Eur J Public Health. 2016;26: 158–168. doi: 10.1093/eurpub/ckv148 26370437
29. Camilloni L, Ferroni E, Cendales BJ, Pezzarossi A, Furnari G, Borgia P, et al. Methods to increase participation in organised screening programs: a systematic review. BMC Public Health. BioMed Central; 2013;13: 464. doi: 10.1186/1471-2458-13-464 23663511
30. Benton SC, Butler P, Allen K, Chesters M, Rickard S, Stanley S, et al. GP participation in increasing uptake in a national bowel cancer screening programme: the PEARL project. Br J Cancer. 2017;116: 1551–1557. doi: 10.1038/bjc.2017.129 28524157
31. Power E, Miles A, von Wagner C, Robb K, Wardle J. Uptake of colorectal cancer screening: system, provider and individual factors and strategies to improve participation. Futur Oncol. 2009;5: 1371–1388. doi: 10.2217/fon.09.134 19903066
32. Shin HY, Suh M, Park B, Jun JK, Choi KS. Perceptions of colorectal cancer screening and recommendation behaviors among physicians in Korea. BMC Cancer. 2017;17: 860. doi: 10.1186/s12885-017-3881-5 29246126
33. Brown T, Lee JY, Park J, Nelson CA, McBurnie MA, Liss DT, et al. Colorectal cancer screening at community health centers: A survey of clinicians’ attitudes, practices, and perceived barriers. Prev Med Reports. 2015;2: 886–891. doi: 10.1016/j.pmedr.2015.09.003 26844165
34. López-Torres-Hidalgo J, Simarro-Herráez MJ, Rabanales-Sotos J, Campos-Rosa R, de-la-Ossa-Sendra B, Carrasco-Ortiz C. The attitudes of primary care providers towards screening for colorectal cancer. Rev Esp Enferm Dig. 105: 272–8. Available: http://www.ncbi.nlm.nih.gov/pubmed/23971658 doi: 10.4321/s1130-01082013000500005 23971658
35. Weiss JM, Pickhardt PJ, Schumacher JR, Potvien A, Kim DH, Pfau PR, et al. Primary Care Provider Perceptions of Colorectal Cancer Screening Barriers: Implications for Designing Quality Improvement Interventions. Gastroenterol Res Pract. 2017;2017: 1–9. doi: 10.1155/2017/1619747 28163715
36. Hudson S V., Ohman-Strickland P, Cunningham R, Ferrante JM, Hahn K, Crabtree BF. The effects of teamwork and system support on colorectal cancer screening in primary care practices. Cancer Detect Prev. 2007;31: 417–423. doi: 10.1016/j.cdp.2007.08.004 18031947
37. Honein-AbouHaidar GN, Kastner M, Vuong V, Perrier L, Daly C, Rabeneck L, et al. Systematic Review and Meta-study Synthesis of Qualitative Studies Evaluating Facilitators and Barriers to Participation in Colorectal Cancer Screening. Cancer Epidemiol Biomarkers Prev. 2016;25: 907–917. doi: 10.1158/1055-9965.EPI-15-0990 27197277
38. Fang CY, Tseng M. Ethnic density and cancer: A review of the evidence. Cancer. 2018;124: 1877–1903. doi: 10.1002/cncr.31177 29411868
39. I.STAT Resident foreigners—Balance [Internet]. [cited 30 Jul 2019]. Available: http://dati.istat.it/Index.aspx?lang=en&SubSessionId=3d9c8597-abbb-4776-b356-2d81f688a807
40. von Wagner C, Baio G, Raine R, Snowball J, Morris S, Atkin W, et al. Inequalities in participation in an organized national colorectal cancer screening programme: results from the first 2.6 million invitations in England. Int J Epidemiol. 2011;40: 712–718. doi: 10.1093/ije/dyr008 21330344
41. Pornet C, Dejardin O, Morlais F, Bouvier V, Launoy G. Socioeconomic determinants for compliance to colorectal cancer screening. A multilevel analysis. J Epidemiol Community Heal. 2010;64: 318–324. doi: 10.1136/jech.2008.081117 19740776
42. Ferroni E, Camilloni L, Jimenez B, Furnari G, Borgia P, Guasticchi G, et al. How to increase uptake in oncologic screening: A systematic review of studies comparing population-based screening programs and spontaneous access. Prev Med (Baltim). 2012;55: 587–596. doi: 10.1016/j.ypmed.2012.10.007 23064024
43. Raine R, Duffy SW, Wardle J, Solmi F, Morris S, Howe R, et al. Impact of general practice endorsement on the social gradient in uptake in bowel cancer screening. Br J Cancer. 2016;114: 321–326. doi: 10.1038/bjc.2015.413 26742011
44. Gupta S, Halm EA, Rockey DC, Hammons M, Koch M, Carter E, et al. Comparative Effectiveness of Fecal Immunochemical Test Outreach, Colonoscopy Outreach, and Usual Care for Boosting Colorectal Cancer Screening Among the Underserved. JAMA Intern Med. 2013;173: 1725–32. doi: 10.1001/jamainternmed.2013.9294 23921906
45. Hughes AG, Watanabe-Galloway S, Schnell P, Soliman AS. Rural–Urban Differences in Colorectal Cancer Screening Barriers in Nebraska. J Community Health. 2015;40: 1065–1074. doi: 10.1007/s10900-015-0032-2 25910484
46. Salas D, Vanaclocha M, Ibáñez J, Molina-Barceló A, Hernández V, Cubiella J, et al. Participation and detection rates by age and sex for colonoscopy versus fecal immunochemical testing in colorectal cancer screening. Cancer Causes Control. 2014;25: 985–997. doi: 10.1007/s10552-014-0398-y 24859111
47. Brenner H, Hoffmeister M, Arndt V, Haug U. Gender differences in colorectal cancer: implications for age at initiation of screening. Br J Cancer. Nature Publishing Group; 2007;96: 828–31. doi: 10.1038/sj.bjc.6603628 17311019
48. Gennep A Van. Les Rites de Passage; Etude Systematique des Rites de la Porte et du Seuil, de l’Hospitalite de l’Adoption, de la Grossesse et de l’Accouchement de la Naissance. Nourry E, editor. Paris: Edité par Librairie Critique; 1909.
49. Janz NK, Wren PA, Schottenfeld D, Guire KE. Colorectal cancer screening attitudes and behavior: a population-based study. Prev Med (Baltim). 2003;37: 627–34. Available: http://www.ncbi.nlm.nih.gov/pubmed/14636796 doi: 10.1016/j.ypmed.2003.09.016 14636796
50. McGregor SE, Bryant HE. Predictors of colorectal cancer screening: a comparison of men and women. Can J Gastroenterol. 2005;19: 343–9. Available: http://www.ncbi.nlm.nih.gov/pubmed/15997267 doi: 10.1155/2005/359243 15997267
51. Stronks K, Kunst AE. The complex interrelationship between ethnic and socio-economic inequalities in health. J Public Health (Bangkok). Oxford University Press; 2009;31: 324–325. doi: 10.1093/pubmed/fdp070
Článek vyšel v časopise
PLOS One
2019 Číslo 10
- S diagnostikou Parkinsonovy nemoci může nově pomoci AI nástroj pro hodnocení mrkacího reflexu
- Je libo čepici místo mozkového implantátu?
- Metamizol jako analgetikum první volby: kdy, pro koho, jak a proč?
- Pomůže v budoucnu s triáží na pohotovostech umělá inteligence?
- AI může chirurgům poskytnout cenná data i zpětnou vazbu v reálném čase
Nejčtenější v tomto čísle
- Correction: Low dose naltrexone: Effects on medication in rheumatoid and seropositive arthritis. A nationwide register-based controlled quasi-experimental before-after study
- Combining CDK4/6 inhibitors ribociclib and palbociclib with cytotoxic agents does not enhance cytotoxicity
- Experimentally validated simulation of coronary stents considering different dogboning ratios and asymmetric stent positioning
- Risk factors associated with IgA vasculitis with nephritis (Henoch–Schönlein purpura nephritis) progressing to unfavorable outcomes: A meta-analysis